Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Hale

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Virology|November 15, 2008
CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215Benjamin G Hale, Axel Knebel, Catherine H Botting, et al.
Nature Communications|August 1, 2019
Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptationPatricia Domingues, Davide Eletto, Carsten Magnus, et al.
The Journal of General Virology|March 19, 2010
Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virusBenjamin G Hale, John Steel, Balaji Manicassamy, et al.
Plos One|April 6, 2011
A transient homotypic interaction model for the influenza A virus NS1 protein effector domainPhilip S Kerry, Juan Ayllon, Margaret A Taylor, et al.
Plos Pathogens|August 20, 2011
Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian speciesMirco Schmolke, Balaji Manicassamy, Lindomar Pena, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activationSadaf Aslam, María T Sánchez-Aparicio, Braden D Siempelkamp, et al.
Plos Biology|March 24, 2021
SARS-CoV-2 variants reveal features critical for replication in primary human cellsMarie O Pohl, Idoia Busnadiego, Verena Kufner, et al.
The Journal of General Virology|July 28, 2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivirMarie O Pohl, Idoia Busnadiego, Francesco Marrafino, et al.
Plos Biology|July 5, 2022
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus diseaseIdoia Busnadiego, Irene A Abela, Pascal M Frey, et al.
Journal of Virology|May 7, 2010
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 proteinBenjamin G Hale, John Steel, Rafael A Medina, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Virology|November 15, 2008
CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215Benjamin G Hale, Axel Knebel, Catherine H Botting, et al.
Nature Communications|August 1, 2019
Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptationPatricia Domingues, Davide Eletto, Carsten Magnus, et al.
The Journal of General Virology|March 19, 2010
Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virusBenjamin G Hale, John Steel, Balaji Manicassamy, et al.
Plos One|April 6, 2011
A transient homotypic interaction model for the influenza A virus NS1 protein effector domainPhilip S Kerry, Juan Ayllon, Margaret A Taylor, et al.
Plos Pathogens|August 20, 2011
Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian speciesMirco Schmolke, Balaji Manicassamy, Lindomar Pena, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activationSadaf Aslam, María T Sánchez-Aparicio, Braden D Siempelkamp, et al.
Plos Biology|March 24, 2021
SARS-CoV-2 variants reveal features critical for replication in primary human cellsMarie O Pohl, Idoia Busnadiego, Verena Kufner, et al.
The Journal of General Virology|July 28, 2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivirMarie O Pohl, Idoia Busnadiego, Francesco Marrafino, et al.
Plos Biology|July 5, 2022
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus diseaseIdoia Busnadiego, Irene A Abela, Pascal M Frey, et al.
Journal of Virology|May 7, 2010
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 proteinBenjamin G Hale, John Steel, Rafael A Medina, et al.
Pageof 7